Through this purchasing, TEDA Holding realized the strategic goal for entering pharmaceutical and health products industry. After purchasing Great Wall company, TEDA Holding is going to increase the investment to expand production scale and build up new GMP standard workshop in TEDA Pharmaceutical Industrial Park, at the same time, pushing forward the developing of new products so as to explore the domestic market actively while continually expanding international market.

Tianjin Great Wall Medical & Health Products Co., Ltd was established in 1989, and since the establishment, the Company mainly focuses on natural botanical drug and natural botanical health products. The Company has the multi ability of grain, tablet, oral liquid, and capsule, which various techniques standards have satisfied with the most advanced level in the same fields all over China. The number of the registered drugs of the Company is more than 200, among which 90% are exported to Japan, Hong Kong, Singapore, with annual sales of exceeding RMB 15 million Yuan.

The land area of the new building of Tianjin TEDA Pharmaceutical Co., Ltd. is about 59805 sq. m, and the construction area is around 16000 sq. m, which will be taken as a modern pharmaceutical enterprise of Chinese medicine focusing on developing, producing Chinese medicine, and reagent for biological engineering.